Alaunos Therapeutics | ZIOP - Cassa E Equivalenti





Cassa E Equivalenti Cambiamento Data
Alaunos Therapeutics USD 354K 1.03M 2026-03
Amgen USD 13.99B 1.95B 2026-06
AstraZeneca USD 4.89B 2.67B 2026-06
Baxter International USD 2.15B 133M 2026-06
Biogen USD 1.28B 2.1B 2026-06
Bioline Rx USD 2.5M 5.41M 2026-03
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Celltrion KRW 56.79B 6.92B 2026-03
Corcept Therapeutics USD 111.04M 2.3M 2026-06
Cspc Pharmaceutical CNY 6.09B 1.48B 2025-12
Curis USD 10.14M 10.14M 2025-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 110.55M 517.12M 2026-06
Divis Laboratories Ltd INR 1.28B 2.87B 2026-03
Gilead Sciences USD 7.63B 64M 2026-03
GlaxoSmithKline GBP 3.44B 292M 2026-03
Incyte USD 3.98B 33.45M 2026-06
Intrexon USD 9.34M 1.77M 2024-06
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
J&J USD 20.42B 1.27B 2026-06
Kangmei Pharma CNY 1.23B 48.16M 2026-03
Karyopharm Therapeutics USD 90.85M 30.31M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Merck USD 6.85B 1.52B 2026-06
Neuren Pharmaceuticals AUD 4.23M 1.68M 2025-12
Novartis USD 7.62B 739M 2026-06
Organigram Holdings CAD 4.29M 3.28M 2026-03
Pfizer USD 976M 727M 2026-06
Pharma Mar EUR 19.34M 29.53M 2026-06
PTC Therapeutics USD 1.05B 215.9M 2026-06
Qiagen NV USD 646.29M 192.72M 2026-03
Regeneron Pharmaceuticals USD 2.46B 506.8M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sartorius EUR 291M 282.8M 2026-06
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
TG Therapeutics USD 612.25M 170.04M 2026-06
Tilray USD 264.83M 43.16M 2025-06
Verastem USD 181.68M 23.31M 2026-03
Zealand Pharma A/S 3.85B 727.54M 2026-03
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03